Published in AIDS Weekly, January 12th, 2009
"However, the clinical utility of the drug is limited by the need for administration by intravenous infusion and the possibility of acute nephrotoxicity. The formation of the lipid conjugate increases in vitro antiviral activity up to a thousandfold, promotes high oral bioavailability and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.